bromocriptine has been researched along with monoiodotyrosine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Tan, LG; Tan, SA | 1 |
| Baxter, LR; Chandra, A; Kamrowski, K; Nguyen, T; Prokai, D; Prokai, L; Talamantes, T | 1 |
3 other study(ies) available for bromocriptine and monoiodotyrosine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Hyperiodotyrosinemia-induced hyperprolactinemia and hyperaldosteronism.
Topics: Adult; Aldosterone; Bromocriptine; Dopamine; Dose-Response Relationship, Drug; Epinephrine; Female; Follicle Stimulating Hormone; Humans; Hyperaldosteronism; Hyperprolactinemia; Hypothyroidism; Luteinizing Hormone; Monoiodotyrosine; Norepinephrine; Prolactin; Thyrotropin; Thyroxine | 1990 |
An exploratory evaluation of tyrosine hydroxylase inhibition in planaria as a model for parkinsonism.
Topics: Animals; Bromocriptine; Humans; Light; Locomotion; Models, Animal; Monoiodotyrosine; Parkinson Disease; Planarians; Protein Binding; Receptors, Dopamine; Tyrosine 3-Monooxygenase | 2013 |